Bio-Rad Laboratories, Inc. Class B share price logo

Bio-Rad Laboratories, Inc. Class B

NYSE: BIO.B

$369.85

-9.65

(-2.54%)

Live

as on

Bio-Rad Laboratories, Inc. Class B Stock Performance

as on November 3, 2026 at 2:25 am IST

  • Day's Low

    Day's High

    $379.50
    $379.50
    downward going graph

    -2.61%

    Downside

    2.61%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $244.54
    $379.50
    downward going graph

    33.88%

    Downside

    2.61%

    Upside

    downward going graph

Bio-Rad Laboratories, Inc. Class B share price movements today

Previous Close
$379.50
Open
$379.50
Volume
98.0
Day's Low - High
$379.50 - $379.50
52 Week Low - High
$244.54 - $379.50

Bio-Rad Laboratories, Inc. Class B Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Bio-Rad Laboratories, Inc. Class B Stock Fundamentals & Key Indicators

Check Bio-Rad Laboratories, Inc. Class B market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

8.33

Dividend Yield

0.00%

PE Ratio (TTM)

44.68

Industry PE ratio

0.00

PEG Ratio

-0.15

Return On Equity TTM

3.15%

Bio-Rad Laboratories, Inc. Class B stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Bio-Rad Laboratories, Inc. Class B with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$-NA44.6851.90%0.00%

Analyst Recommendation on Bio-Rad Laboratories, Inc. Class B Stock

Based on 10 analysts

BUY

60.00%

Buy

40.00%

Hold

0.00%

Sell

Indian Investors' Interest in Bio-Rad Laboratories, Inc. Class B Stock

Search interest for Bio-Rad Laboratories, Inc. Class B Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-63% versus previous 30 day period

Bio-Rad Laboratories, Inc. Class B Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
610
638
649
667
585
651
653
693
592
651
Gross Profit
326
355
355
341
306
345
343
345
309
345
Operating Income
52
101
64
58
23
77
66
61
34
72
EBITDA
540
-2,737
912
-847
133
467
-374
983
-636
542
Interest Expense
12
12
12
12
12
12
12
12
12
-
Depreciation
37
36
38
49
38
40
44
42
40
-
Income Before Tax
491
-2,786
861
-908
83
414
-431
929
-689
542
Income Tax Expense
107
-620
208
-193
19
96
-89
209
-162
170
Net Income
383
-2,165
653
-715
64
317
-341
720
-527
371
Net Profit Margin
53.45%
55.62%
54.78%
51.22%
52.27%
52.99%
52.59%
49.80%
52.25%
53.12%

Bio-Rad Laboratories, Inc. Class B Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2,160
2,290
2,311
2,545
2,922
2,802
2,671
2,566
2,583
Gross Profit
1,187
1,224
1,256
1,437
1,638
1,567
1,426
1,378
1,343
Operating Income
116
-108
229
421
500
482
337
269
270
EBITDA
269
674
2,418
5,078
5,588
-4,528
-654
-2,142
1,209
Interest Expense
23
23
23
21
1
38
49
48
49
Depreciation
148
138
134
138
137
137
145
151
165
Income Before Tax
97
507
2,261
4,918
5,449
-4,704
-850
-2,342
995
Income Tax Expense
-16
146
502
1,103
1,194
-1,076
-212
-498
235
Net Income
114
360
1,758
3,814
4,254
-3,627
-637
-1,844
759
Net Profit Margin
54.97%
53.46%
54.38%
56.48%
56.05%
55.93%
53.42%
53.73%
52.01%

Bio-Rad Laboratories, Inc. Class B Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
383
-2,165
653
-715
64
-120
-341
720
-527
-13
Operating Cash Flow
69
97
163
124
129
116
120
164
108
98
Investing Cash Flow
-43
-30
-55
-30
2
-115
-43
-34
-93
-66
Financing Cash Flow
0
-96
-95
-26
-97
-136
-52
3
-44
-27
Change in Cash
29
-26
4
77
33
-151
26
131
-23
9

Bio-Rad Laboratories, Inc. Class B Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
122
365
1,758
3,814
4,254
-3,627
-637
-1,844
759
Operating Cash Flow
104
285
457
584
669
194
374
455
532
Investing Cash Flow
-175
-186
-208
-69
-797
-1,207
20
-160
-189
Financing Cash Flow
0
-48
-22
-523
-55
973
-425
-218
-283
Change in Cash
-72
49
228
4
-195
-36
-30
85
40

Global Institutional Holdings in Bio-Rad Laboratories, Inc. Class B

Check out the Institutions with significant holdings in Bio-Rad Laboratories, Inc. Class B.

Funds
Holdings
Jonathan Divincenzo
0.06%

Bio-Rad Laboratories, Inc. Class B News & Key Events

    Insights on Bio-Rad Laboratories, Inc. Class B

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Best in 1 Year

      img

      In the last 1 year, BIO.B has outperformed top 5 stocks with highest market-cap in its industry

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 1 month, BIO.B stock has moved up by 7.2%

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, BIO.B has outperformed top 5 stocks with highest market-cap in its industry

    About Bio-Rad Laboratories, Inc. Class B

    Bio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics. Its operations span globally, covering territories such as the United States, Europe, Asia, Canada, and Latin America. The company's business is organized into two main divisions: Life Science and Clinical Diagnostics. The Life Science division develops and provides a comprehensive array of reagents, laboratory apparatus, and instruments. These are vital for various applications, including scientific research methodologies, biopharmaceutical production processes, and food quality testing. This segment dedicates its efforts to key areas within the life sciences, such as proteomics, genomics, biopharmaceutical development, cellular biology, and ensuring food safety. Its diverse clientele includes academic institutions (universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology researchers, and both food producers and testing laboratories. Conversely, the Clinical Diagnostics division specializes in designing, producing, selling, and supporting diagnostic test systems, informatics solutions, test kits, and specific quality control measures for clinical laboratories. This segment furnishes reagents, instrumentation, and software precisely tailored to address particular requirements within the in vitro diagnostics market. Its products are utilized by reference laboratories, hospital labs, state-operated newborn screening facilities, physicians' private offices, and blood transfusion centers. Furthermore, Bio-Rad offers systems and products designed for separating intricate chemical and biological substances, as well as for identifying, analyzing, and purifying their individual components. The company distributes its offerings through a multi-channel approach, leveraging both its direct sales force and a network of distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was established in 1952 and its corporate headquarters are located in Hercules, California.
    OrganisationBio-Rad Laboratories, Inc. Class B
    Headquarters1000 Alfred Nobel Drive, Hercules, CA, 94547, US
    IndustryMedical - Devices
    CEONorman D. Schwartz

    FAQs

    What is Bio-Rad Laboratories, Inc. Class B share price today?

    Bio-Rad Laboratories, Inc. Class B share price today is $369.85 as on . Bio-Rad Laboratories, Inc. Class B share today touched a day high of $379.50 and a low of $379.50.

    What is the 52 week high and 52 week low for Bio-Rad Laboratories, Inc. Class B share?

    Bio-Rad Laboratories, Inc. Class B share touched a 52 week high of $379.50 on and a 52 week low of $244.54 on . Bio-Rad Laboratories, Inc. Class B stock price today i.e. is trending at $369.85,which is 2.54% down from its 52 week high and 51.24% up from its 52 week low.

    How to invest in Bio-Rad Laboratories, Inc. Class B Stock (BIO.B) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Bio-Rad Laboratories, Inc. Class B on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy Bio-Rad Laboratories, Inc. Class B Stock (BIO.B) from India?

    Indian investors can start investing in Bio-Rad Laboratories, Inc. Class B (BIO.B) shares with as little as ₹94.9000015258789 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹949.00 in Bio-Rad Laboratories, Inc. Class B stock (as per the Rupee-Dollar exchange rate as on ). Based on Bio-Rad Laboratories, Inc. Class B share’s latest price of $369.85 as on November 2, 2026 at 8:55 pm IST, you will get 0.0270 shares of Bio-Rad Laboratories, Inc. Class B. Learn more about fractional shares .